Skip to main content


Table 1 Laboratory data on admission

From: Scleroderma renal crisis with coexisting segmental arterial mediolysis presenting as intraperitoneal bleeding: a case report

Laboratory test Result
Complete blood count
 White blood cells 16,650/μl
 Neutrophils 91%
 Red blood cells 264 × 106/μl
 Hemoglobin 8.2 g/dl
 Hematocrit 25.9%
 Mean corpuscular volume 98 fl
 Mean corpuscular hemoglobin 31 pg
 Platelet 17.9 × 104/μl
 PT-INR 1.01
 APTT 31 s
 Total protein 5 g/dl
 Albumin 2.9 g/dl
 Total bilirubin 0.49 mg/dl
 Aspartate aminotransferase 32 U/L
 Alanine aminotransferase 47 U/L
 Lactate dehydrogenase 636 U/L
 C-reactive protein 0.63 mg/dl
 Sodium 133 mEq/L
 Potassium 4.9 mEq/L
 Blood urea nitrogen 127 mg/dl
 Creatinine 6.6 mg/dl
 Estimated glomerular filtration rate 5.4 ml/min/1.73 m2
 Brain natriuretic peptide 4566 pg/ml
 Plasma renin activity ≥ 20 ng/ml/h
 Plasma aldosterone concentration 433 pg/ml
Autoantibody test
 Antinuclear antibody 320 index (speckled pattern)
 Anti-RNA polymerase III antibody ≥150
 Anti-topoisomerase I antibody Negative
 Anti-centromere antibody Negative
 Anti-RNP antibody Negative
 Anti-SSA antibody Negative
 Anti-SSB antibody Negative
 PR3-ANCA < 1.0 IU/ml
 MPO-ANCA 1.1 IU/ml
 pH 5
 Specific gravity 1.012
 Protein 2+
 Occult blood 3+
 Red blood cells 1–4/LPF
 White blood cells Countless/HPF
 Epithelial cell casts 1–4/HPF
 Granular casts 1–4/LPF
 Waxy casts 1–4/whole field
 NAG 20 U/L
 β2-Microglobulin 321 μg/L
24-h urine collection
 Urinary volume 290 ml/day
 Creatinine clearance 1.3 ml/min
 Protein 354 mg/day
 Glucose 0.03 g/day
  1. Abbreviations: PT-INR prothrombin time-international normalized ratio, APTT activated partial thromboplastin time, anti-RNA polymerase III antibody anti-ribonucleic acid polymerase III antibody, anti-RNP antibody anti-ribonucleoprotein antibody, anti-SSA antibody anti-Sjögren’s syndrome-related antigen A antibody, anti-SSB antibody anti-Sjögren’s syndrome-related antigen B antibody, PR3-ANCA proteinase-3-antineutrophil cytoplasmic antibody, MPO-ANCA myeloperoxidase-antineutrophil cytoplasmic antibody, LPF low-power field, HPF high-power field, NAG N-acetyl-β-D-glucosaminidase